Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» What This FDA News Could Mean for AbbVie's Stock
What This FDA News Could Mean for AbbVie's Stock
What This FDA News Could Mean for AbbVie's Stock
Submitted by
admin
on January 24, 2022 - 10:10am
Source:
Motley Fool
News Tags:
AbbVie
Rinvoq
FDA
Headline:
What This FDA News Could Mean for AbbVie's Stock
snippet:
If approved, Rinvoq would gain access to nearly 200,000 potential patients.
The indication could generate $500 million in annual revenue for AbbVie.
AbbVie still looks like a great dividend growth stock for income investors.
Do Not Allow Advertisers to Use My Personal information
